🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery

Recruitingn/aAges 18 Years - anyAllOndokuz Mayıs University
NCT07500376 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This prospective observational cohort study aims to evaluate the prognostic value of multimodal nutritional status and sarcopenia assessment in patients undergoing lung cancer surgery. Postoperative complications, mortality, and prolonged hospital stay remain major clinical concerns in thoracic surgery. Although malnutrition and sarcopenia are recognized as important determinants of surgical outcomes, their combined and multidimensional evaluation has not been sufficiently studied. Adult patients undergoing anatomical lung resection for primary lung cancer will be included. Nutritional status will be assessed using serum biomarkers, inflammatory indices, and validated clinical nutritional scores. Sarcopenia will be evaluated using computed tomography-based muscle mass and density measurements, as well as ultrasonographic muscle thickness. These parameters will be analyzed in relation t

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age ≥18 years * Patients undergoing anatomical lung resection (lobectomy or segmentectomy) for primary lung cancer * Availability of preoperative thoracic computed tomography (CT) within 30 days before surgery * Completion of preoperative nutritional assessment and ultrasonographic muscle measurements * Ability to provide written informed consent Exclusion Criteria: * Receipt of neoadjuvant chemotherapy, immunotherapy, or radiotherapy * Emergency surgery * Pneumonectomy * Combined resection of another organ during the same procedure * Inadequate or non-evaluable imaging or measurement data * Immunosuppressive therapy or presence of advanced/metastatic disease * Significant thoracic deformity or prior conditions interfering with muscle measurements * Refusal or inability to provide informed consent
💊

What it tests

  • Observational Assessment
📍

Where

1 site
Ondokuz Mayis University Faculty of Medicine, Department of Thoracic Surgery
Samsun, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy